Involvement_NN
of_IN
the_DT
N-terminal_JJ
region_NN
of_IN
the_DT
human_JJ
mineralocorticoid_NN
receptor_NN
hormone-binding_NN
domain_NN
in_IN
agonist_NN
and_CC
antagonist_NN
binding_NN
as_RB
revealed_VBD
by_IN
a_DT
new_JJ
monoclonal_JJ
antibody_NN
._.

To_TO
gain_VB
a_DT
better_JJR
understanding_NN
of_IN
the_DT
mechanism_NN
of_IN
binding_NN
to_TO
the_DT
human_JJ
mineralocorticoid_NN
receptor_NN
-LRB-_-LRB-
hMR_NN
-RRB-_-RRB-
,_,
we_PRP
developed_VBD
a_DT
new_JJ
monoclonal_JJ
antibody_NN
-LRB-_-LRB-
mAb_NN
-RRB-_-RRB-
raised_VBN
against_IN
the_DT
hormone-binding_JJ
domain_NN
-LRB-_-LRB-
HBD_NN
-RRB-_-RRB-
._.

For_IN
this_DT
purpose_NN
,_,
mice_NNS
were_VBD
immunized_VBN
with_IN
a_DT
fusion_NN
protein_NN
including_VBG
the_DT
sequence_NN
Thr729-Lys984_NN
of_IN
hMR_NN
._.

After_IN
ELISA_NN
screening_NN
,_,
mAb_NN
18C7_NN
was_VBD
selected_VBN
for_IN
its_PRP$
specificity_NN
towards_IN
the_DT
HBD_NN
._.

This_DT
antibody_NN
recognized_VBD
both_CC
the_DT
denatured_VBN
and_CC
native_JJ
MR_NN
forms_NNS
,_,
as_RB
well_RB
as_IN
the_DT
hetero-oligomeric_JJ
MR_NN
form_NN
and_CC
the_DT
transformed_VBN
MR_NN
state_NN
._.

By_IN
using_VBG
several_JJ
HBD_NN
subfragments_NNS
,_,
the_DT
mAb_NN
18C7_NN
epitope_NN
was_VBD
located_JJ
in_IN
the_DT
N-terminal_JJ
region_NN
of_IN
the_DT
HBD_NN
from_IN
Thr729_NN
to_TO
Leu765_NN
._.

We_PRP
then_RB
studied_VBD
the_DT
effect_NN
of_IN
the_DT
antibody_NN
on_IN
aldosterone_NN
and_CC
progesterone_NN
binding_NN
to_TO
the_DT
hMR_NN
._.

When_WRB
18C7_NN
was_VBD
incubated_VBN
with_IN
liganded_JJ
MR_NN
,_,
it_PRP
was_VBD
able_JJ
to_TO
partly_RB
displace_VB
-LRB-_-LRB-
20_CD
%_NN
-RRB-_-RRB-
the_DT
hormone_NN
from_IN
its_PRP$
binding_VBG
site_NN
._.

When_WRB
18C7_NN
was_VBD
incubated_VBN
with_IN
MR_NN
before_IN
aldosterone_NN
or_CC
progesterone_NN
,_,
the_DT
antibody_NN
inhibited_VBD
75-80_CD
%_NN
of_IN
the_DT
binding_NN
._.

The_DT
effect_NN
of_IN
18C7_NN
on_IN
the_DT
binding_NN
was_VBD
similar_JJ
with_IN
both_DT
hormones_NNS
._.

A_DT
sucrose_NN
gradient_NN
analysis_NN
indicated_VBD
the_DT
simultaneous_JJ
presence_NN
of_IN
two_CD
kinds_NNS
of_IN
receptor_NN
complexes_NNS
:_:
the_DT
steroid-MR_JJ
complex_NN
and_CC
the_DT
antibody-MR_JJ
complex_NN
._.

After_IN
its_PRP$
associated_VBN
proteins_NNS
,_,
especially_RB
the_DT
heat-shock_JJ
protein_NN
hsp90_NN
,_,
had_VBD
been_VBN
cross-linked_VBN
with_IN
the_DT
hMR_NN
by_IN
dimethylpimelimidate_NN
,_,
18C7_NN
was_VBD
still_RB
able_JJ
to_TO
react_VB
with_IN
the_DT
receptor_NN
._.

Our_PRP$
results_NNS
indicated_VBD
that_IN
the_DT
epitope_NN
recognized_VBN
by_IN
18C7_NN
was_VBD
directly_RB
implicated_VBN
in_IN
hormone_NN
binding_NN
._.

The_DT
lack_NN
of_IN
steroid_NN
binding_NN
of_IN
HBD_NN
mutants_NNS
with_IN
the_DT
Thr729-Leu765_JJ
sequence_NN
deleted_VBN
-LCB-_-LRB-
Jalaguier_NNP
,_,
Mesnier_NNP
,_,
Leger_NNP
and_CC
Auzou_NNP
-LRB-_-LRB-
1996_CD
-RRB-_-RRB-
J._NN
Steroid_NN
Biochem_NNP
._.
Mol_NNP
._.
Biol_CD
.57_CD
,_,
43-50_CD
-RCB-_-RRB-
supports_VBZ
this_DT
hypothesis_NN
._.

Because_IN
of_IN
the_DT
similar_JJ
behaviors_NNS
of_IN
aldosterone_NN
and_CC
progesterone_NN
,_,
we_PRP
conclude_VBP
that_IN
the_DT
N-terminal_JJ
Thr729-Leu765_JJ
region_NN
of_IN
the_DT
HBD_NN
is_VBZ
similarly_RB
involved_VBN
in_IN
the_DT
binding_NN
of_IN
both_DT
hormones_NNS
._.

